QR Kodea

Adjunctive rifampicin to reduce early mortality from <it>Staphylococcus aureus</it> bacteraemia (ARREST): study protocol for a randomised controlled trial

<p>Abstract</p> <p>Background</p> <p><it>Staphylococcus aureus</it> bacteraemia is a common and serious infection, with an associated mortality of ~25%. Once in the blood, <it>S. aureus</it> can disseminate to infect almost any organ, but bones, joints and heart valves are most frequently affected....

Deskribapen osoa

Gorde:
Egile Nagusiak: Thwaites Guy, Auckland Cressida, Barlow Gavin, Cunningham Richard, Davies Gerry, Edgeworth Jonathan, Greig Julia, Hopkins Susan, Jeyaratnam Dakshika, Jenkins Neil, Llewelyn Martin, Meisner Sarah, Nsutebu Emmanuel, Planche Tim, Read Robert C, Scarborough Matthew, Soares Marta, Tilley Robert, Török M Estée, Williams John, Wilson Peter, Wyllie Sarah, Walker A Sarah
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2012-12-01
Saila:Trials
Gaiak:
<it>Staphylococcus aureus</it>
Bacteraemia
Rifampicin
Mortality
Sarrera elektronikoa:http://www.trialsjournal.com/content/13/1/241
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak